Microsoft word - nutrsg10.doc
Chapter 10:Study Guide
1. Which tissues comprise total body fat and which comprise fat- free mass? 2. Discuss conditions in which fat cells can increase in size and number. 3. Why is it necessary to have some body fat? 4. List three roles for subcutaneous fat. 5. What is visceral fat? 6. What is cellulite? 7. Describe at least two differences between brown fat tissues and white fat tissue. 8. Describe three different methods of measuring body fat, including drawbacks of
9. Explain why a healthy woman has more body fat that a healthy man. 10. A young man’s body is 13% fat. According to information in Table 10.1, is he
11. Using the “rule of thumb” formula, estimate the daily basal metabolic energy
12. List the four major ways the body uses the most energy on a daily basis? 13. For most people, which form of energy expenditure uses the most energy on a
14. Discuss at least five factors that influence basal metabolic rate. 15. Of the four major ways the body uses energy, which one is most easily altered? 16. Explain the differences between TEF and energy needs for physical activity. 17. What is NEAT? List at least three ways the body expends energy by NEAT.
18. What happens to a person’s body weight when he or she is in a state of postitive
19. When is it desirable for a person to be in a positive energy balance state? 20. When is a person in a negative energy balance state? 21. A young woman’s BMI is 26.2. According to this information, is this woman likely
to be healthy, overweight, obese, or extremely obese?
22. List at least six different serious health problems that are associated with having
too much body fat and being obese in particular.
23. What is the “stigma” of obesity? 24. Which of the two major types of body fat distribution is more likely to pose
serious health risks? Which chronic diseases are more likely to develop in people who have this pattern of excess fat deposition?
25. What is a quick and easy way to determine whether a person’s body fat
distribution is likely to result in serious health problems, such as type 2 diabetes?
26. What is hunger? What is satiety? 27. Discuss the roles of leptin and ghrelin in regulating hunger. 28. Under what conditions would having “thrifty genes” benefit a person? 29. What is the set- point theory? 30. What is the difference between hunger and appetite? 31. Describe how the environment influences a person’s food intake and physical
32. Provide at least three examples of ways that socioeconomic, psychological, and
societal factors can influence eating behavior.
33. What are the four key elements that are necessary for weight loss and
34. List at least six features of reliable weight-loss plans or programs. 35. What questions would it be wise for consumers to have answered before they
36. List at least three steps that members of the National Weight Control Registry
often take to maintain their reduced body weights.
37. Explain how orlistat (Xenical) can aid weight-loss efforts. 38. Describe the two most common types of bariatric surgery in the United States.
Why is bariatric surgery effective? Compared to gastric stapling procedures, what is a major advantage of gastric banding?
39. What is liposuction? List three risks associated with this procedure. 40. What is a “fad” diet? List at least four typical features of fad diets. 41. Why do fad diets and dietary supplements promoted for weight loss appeal to
42. Identify at least four popular weight- loss supplements and indicate whether each
43. Discuss at least three features or claims that are commonly used in ads for
44. List at least three health conditions that are often associated with underweight. 45. Discuss at least three measures an underweight person can take to gain lean
PRESCRIBING INFORMATION OMNIPAQUE™ (iohexol) Please refer to full national Summary of Product Characteristics (SPC) before prescribing. Indications and approvals may vary in different countries. Further information available on request. PRESENTATION Aqueous solution for injection containing iohexol, a non-ionic, monomeric, triiodinated X-ray contrast medium, and available in streng
July/August 2000 NEW DRUGS VI Rosiglitazone (Avandia®) Approved indication: To lower blood glucose in patients with type 2 diabetes not controlled by diet and exercise alone: 1) as monotherapy or 2) in addition to maximum doses of metformin. Mechanism of action: Agonist for the peroxisome proliferator-activated receptor by which it decreases insulin resistance in muscle and adipose t